Loredana Cifaldi
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: May 04, 2026
Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes.
Journal: Journal of translational medicine
Published: February 22, 2026
Correction: Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing.
Journal: Cell death & disease
Published: January 21, 2026
Extracellular Vesicle-Derived microRNAs: Novel Non-Invasive Biomarkers for Gastrointestinal Malignancies.
Journal: International journal of molecular sciences
Published: November 14, 2025
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer.
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer.
Journal: Cell death discovery
Published: November 10, 2025
Chronic low-dose cadmium exposure accelerates the onset and metastasis of invasive mammary carcinoma and promotes immunosuppression in the tumor microenvironment in BALB-neuT mice.
Journal: Ecotoxicology and environmental safety
Published: August 06, 2025
Combining Chemotherapeutic Agents, Targeted Therapies, Vaccines and Natural Bioactive Compounds for Mesothelioma: Advances and Perspectives.
Journal: Oncology research
Published: April 15, 2025
In vitro synergistic effect of AXL, FAK and ErbB receptors inhibitors for head and neck cancer.
Journal: Biology direct
Published: February 28, 2025
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing.
Journal: Cell death & disease
Published: January 21, 2025
Immunogenic Cell Death Inducers in Cancer Immunotherapy to Turn Cold Tumors into Hot Tumors.
Journal: International journal of molecular sciences
Published: December 31, 2024
A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.
Journal: Frontiers in immunology
Published: December 01, 2024
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity.
Journal: Experimental hematology & oncology
Published: October 30, 2024
Last Updated: 09/26/2026